In case you didn’t notice, the MLB Home Run Derby was last night with Prince Fielder beating out Jose Bautista in the final round at Kauffman Stadium in Kansas City, MO. What many will notice is tonight’s MLB All Star game which will have the youngest player ever, MusclePharm Corp. (MSLP) spokesperson Bryce Harper. MSLP stock price has been a tear lately just like the Washington Nationals’ 19 year old rookie outfielder gaining 68.22% at the HOD since their restatement or financial statements from prior quarters.
Looking for Hot Penny Stocks? Click here and get Alerts on the Best Penny Stocks FREE.
MSLP Stock Chart
Most Recent Quarter
(mrq): Mar 31, 2012
Revenue (ttm): 34.37M
Revenue Per Share (ttm): 0.06
Qtrly Revenue Growth (yoy): 445.80%
Gross Profit (ttm): 2.37M
EBITDA (ttm): -15.61M
Net Income Avl to Common (ttm): -34.30M
Diluted EPS (ttm): -0.06
Total Cash (mrq): 1.30M
Total Debt (mrq): 1.43M
Current Ratio (mrq): 0.26
Operating Cash Flow (ttm): -3.51M
Investors are salivating to get their eyes on MusclePharm’s Q2 earnings report. With the expansion projects in the retail line as well as additional products made available for retail, MSLP could shock traders breaking their 52 week high of 0.04.
On May 14, 2012, MusclePharm’s independent registered public accounting firm and the Company’s board of directors determined, after consultation with MusclePharm management, that the following financial statements contained misstatements:
(i) MusclePharm’s audited financial statements for the year ended December 31, 2011, filed in an annual report on Form 10-K with the U.S. Securities and Exchange Commission on April 16, 2012;
(ii) MusclePharm’s unaudited financial statements for the period ended September 30, 2011, filed in a quarterly report on Form 10-Q with the SEC on November 14, 2011;
(iii) MusclePharm’s unaudited financial statements for the period ended June 30, 2011, filed in a quarterly report on Form 10-Q with the SEC on August 16, 2012; and
(iv) MusclePharm’s unaudited financial statements for the period ended March 31, 2011, filed in a quarterly report on Form 10-Q with the SEC on May 24, 2012.
All amended financial statements were filed with the SEC on, or before, July 2, 2012. Click here to view the SEC filings for MSLP.
About MSLP Stock
MusclePharm Corp. is a rapidly expanding healthy life-style company that develops and distributes a full line of National Sanitation Foundation International and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the National Football League, mixed martial arts, and Major League Baseball. The Company’s propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets, including GNC, Vitamin Shoppe, and Vitamin World. The Company also sells its products in over 100 online stores, including bodybuilding.com, amazon.com and vitacost.com.
Bottom Line: Get to know the penny stock of MuslcePharm Corp., MSLP, and get it on your list of penny stocks to watch immediately. MSLP has made a name for itself in the fitness and health arenas with their sponsorship of many UFC televised fights. With their recent agreement with Bryce Harper, many doubt the impact that it can have except for those who saw what Michael Jordan did for Gatorade.
Here is your opportunity to subscribe to the Most Exclusive Penny Stock newsletter.
Sign up with your email address now & get ready to make BIG PROFITS on Good Penny Stocks
(We are 100% Anti-Spam and will never rent or sell your information)Share